Clinical Trial Detail

NCT ID NCT04424966
Title Infigratinib in Recurrent Glioblastoma Patients
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements Yes
Sponsors Nader Sanai
Indications

malignant glioma

Therapies

Infigratinib

Age Groups: senior adult

Additional content available in CKB BOOST